Cytotoxic Chemotherapy
134 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Cytotoxic Chemotherapy (117)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Glufosfamide |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Glufosfamide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Hydroxyurea |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Hydroxyurea
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Idarubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Idarubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Ifosfamide |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Ifosfamide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Irinotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Irinotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Ixabepilone |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Ixabepilone
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Larotaxel |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Larotaxel
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Liposomal Cytarabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Cytarabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Liposomal Daunorubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Daunorubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Liposomal Doxorubicin (Pegylated) |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Doxorubicin (Pegylated)
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Liposomal Irinotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Irinotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Liposomal Vincristine |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Liposomal Vincristine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
GlufosfamideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
HydroxyureaCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
IdarubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
IfosfamideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
IrinotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
IxabepiloneCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
LarotaxelCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
Liposomal CytarabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Liposomal DaunorubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Liposomal Doxorubicin (Pegylated)Cytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Liposomal IrinotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
Liposomal VincristineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|